Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy

K. J. Pienta*, E. U. Hammarlund, R. H. Austin, R. Axelrod, J. S. Brown, S. R. Amend

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


Unusually large cancer cells with abnormal nuclei have been documented in the cancer literature since 1858. For more than 100 years, they have been generally disregarded as irreversibly senescent or dying cells, too morphologically misshapen and chromatin too disorganized to be functional. Cell enlargement, accompanied by whole genome doubling or more, is observed across organisms, often associated with mitigation strategies against environmental change, severe stress, or the lack of nutrients. Our comparison of the mechanisms for polyploidization in other organisms and non-transformed tissues suggest that cancer cells draw from a conserved program for their survival, utilizing whole genome doubling and pausing proliferation to survive stress. These polyaneuploid cancer cells (PACCs) are the source of therapeutic resistance, responsible for cancer recurrence and, ultimately, cancer lethality.

TidsskriftSeminars in Cancer Biology
StatusE-pub ahead of print - 1. dec. 2020


Dyk ned i forskningsemnerne om 'Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy'. Sammen danner de et unikt fingeraftryk.